Literature DB >> 26391049

Clinical Assessment of Cognitive Decline in Adults with Down Syndrome.

Marwan Sabbagh1, Jamie Edgin.   

Abstract

Down syndrome is an intellectual disability requiring periodic monitoring of cognition given the near universal presence of Alzheimer's Disease related neuropathology and high rates of dementia in middle adulthood. We review current approaches to detecting decline in this population, including informant-based measures, dementia screening tools, and neuroimaging techniques. The challenges for detecting decline in this group are discussed, including the need to take into account premorbid cognitive function as well as medical comorbidity.

Entities:  

Mesh:

Year:  2016        PMID: 26391049     DOI: 10.2174/1567205012666150921095724

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  15 in total

1.  The Link between Alzheimer's Disease and Down Syndrome. A Historical Perspective.

Authors:  Ahmad Salehi; J Wesson Ashford; Elliott J Mufson
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

2.  Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.

Authors:  Alexander M Kleschevnikov; Jessica Yu; Jeesun Kim; Larisa V Lysenko; Zheng Zeng; Y Eugene Yu; William C Mobley
Journal:  Neurobiol Dis       Date:  2017-03-22       Impact factor: 5.996

3.  The AT(N) framework for Alzheimer's disease in adults with Down syndrome.

Authors:  Michael S Rafii; Beau M Ances; Nicole Schupf; Sharon J Krinsky-McHale; Mark Mapstone; Wayne Silverman; Ira Lott; William Klunk; Elizabeth Head; Brad Christian; Florence Lai; H Diana Rosas; Shahid Zaman; Melissa E Petersen; Andre Strydom; Juan Fortea; Benjamin Handen; Sid O'Bryant
Journal:  Alzheimers Dement (Amst)       Date:  2020-10-27

4.  Down syndrome with posterior cortical atrophy.

Authors:  Claire Boutoleau-Bretonnière; Amandine Pallardy
Journal:  BMJ Case Rep       Date:  2018-02-08

5.  Blood-based biomarkers for Down syndrome and Alzheimer's disease: A systematic review.

Authors:  Melissa E Petersen; Sid E O'Bryant
Journal:  Dev Neurobiol       Date:  2019-09-03       Impact factor: 3.964

6.  The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.

Authors:  Alain D Dekker; Aurora M Ulgiati; Henk Groen; Vincent A Boxelaar; Silvia Sacco; Ségolène Falquero; Angelo Carfi; Antonella di Paola; Bessy Benejam; Silvia Valldeneu; Roelie Fopma; Marjo Oosterik; Marloes Hermelink; Gonny Beugelsdijk; Mieke Schippers; Hepie Henstra; Martine Scholten-Kuiper; Judith Willink-Vos; Lisa de Ruiter; Liesbeth Willems; Anneke Loonstra-de Jong; Antonia M W Coppus; Marleen Tollenaere; Juan Fortea; Graziano Onder; Anne-Sophie Rebillat; Debby Van Dam; Peter P De Deyn
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 7.  The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies.

Authors:  Bianca Alexandra Lautarescu; Anthony John Holland; Shahid H Zaman
Journal:  Neuropsychol Rev       Date:  2017-03-13       Impact factor: 7.444

Review 8.  A Review of Biomarkers for Alzheimer's Disease in Down Syndrome.

Authors:  Ni-Chung Lee; Yin-Hsiu Chien; Wuh-Liang Hwu
Journal:  Neurol Ther       Date:  2017-07-21

9.  Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome.

Authors:  Sid E O'Bryant; Fan Zhang; Wayne Silverman; Joseph H Lee; Sharon J Krinsky-McHale; Deborah Pang; James Hall; Nicole Schupf
Journal:  Alzheimers Dement (Amst)       Date:  2020-05-21

Review 10.  Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome.

Authors:  Natalie Neale; Concepcion Padilla; Luciana Mascarenhas Fonseca; Tony Holland; Shahid Zaman
Journal:  Neuroimage Clin       Date:  2017-11-06       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.